Hollis-Hansen, Kelseanna
Haskins, Carolyn
Turcios, Jessica
Bowen, Michael E.
Leonard, Tammy
Lee, MinJae
Albin, Jaclyn
Wadkins-Chambers, Benaye
Thompson, Cynthia
Hall, Taylor
Pruitt, Sandi L.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR003163)
UT Southwestern Medical Center Program for the Evaluation and Development of Model Community Health Initiatives Community-Based Research Award
Article History
Received: 6 June 2023
Accepted: 28 November 2023
First Online: 1 December 2023
Declarations
:
: This study was conducted in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki). This study was deemed minimal risk and approved by the UT Southwestern Medical Center Institutional Review Board (Identifier: <b>STU-2022-0809</b>). Participants were read the consent form by research staff and provided verbal consent after it was confirmed all questions were addressed and participants indicated a desire to participate. Verbal informed consent was approved by the UT Southwestern Medical Center Institutional Review Board and was obtained from all participants. Time and date of verbal consent were recorded by study staff.
: Not applicable.
: Unrelated to this work, Sandi Pruitt receives consulting fees from Pfizer. All other authors declare that they have no competing interests.